|Slideshows|October 5, 2017

What’s New in the Treatment of MDD?

The latest news in the treatment of depression covers patient self-management apps, antidepressant efficacy in older adults, and strategies to improve adherence.

View the slides in PDF format.

Newsletter

Receive trusted psychiatric news, expert analysis, and clinical insights — subscribe today to support your practice and your patients.

Subscribe Now!

Related Content

Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia

ByJessica Walters

December 27th 2025

Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics

ByJessica Walters

December 24th 2025

FDA Approves First At-Home Brain Stimulation Device for Treatment of Depression

ByJessica Walters

December 12th 2025

Managing Treatment-Resistant Depression: Insights From David Medina, MD, FAPA

ByDavid Medina, MD, FAPA

December 2nd 2025

Looking Back: Key Insights from November 2025

ByJessica Walters

November 28th 2025

What’s New in the Treatment of MDD?

Newsletter

Related Content

Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia

Programs for ST-905 and ST-905 for Schizophrenia and Depression Launched by Syremis Therapeutics

FDA Approves First At-Home Brain Stimulation Device for Treatment of Depression

Managing Treatment-Resistant Depression: Insights From David Medina, MD, FAPA

Looking Back: Key Insights from November 2025

Trending on Psychiatric Times

Research Recap From the European College of Neuropsychopharmacology Congress

Southern California Psychiatry: Review of New Agents in Schizophrenia and Dementia

AI in 2025: A Look Back With Allen Frances, MD

Latest Alzheimer Disease Data: Reports from CTAD 2025

Breakage